新诊断1型糖尿病儿童早期与延迟胰岛素泵治疗的比较:多中心前瞻性DPV登记研究结果
该研究基于德国、奥地利、瑞士和卢森堡501个糖尿病中心的DPV前瞻性登记数据,纳入2004至2014年诊断、诊断年龄6个月至15岁、且在诊断后6个月内(早期组)或第2至3年(延迟组)开始胰岛素泵治疗并持续至少1年的8332例1型糖尿病患儿。
核心结论
- 在新诊断1型糖尿病儿童中,早期启动胰岛素泵治疗与更低的HbA1c、更低的低血糖昏迷和住院率以及更优的部分心血管风险指标相关。
研究设计与样本
- 基于DPV多中心前瞻性糖尿病随访登记(德国、奥地利、瑞士、卢森堡501个中心)的队列研究。
- 纳入2004至2014年诊断、诊断年龄6个月至15岁、诊断后6个月内(早期组)或第2至3年(延迟组)开始胰岛素泵治疗且持续至少1年的患者。
- 统计模型调整了诊断年龄、诊断年份、性别、移民背景、连续血糖监测使用、中心规模和德国社会经济剥夺指数2012三分位。
关键数值与推荐
- 早期治疗组定义为诊断后6个月内开始胰岛素泵治疗,延迟治疗组定义为诊断后第2至3年开始。
临床怎么用
- 对于新诊断的1型糖尿病儿童,在诊断后6个月内早期启动胰岛素泵治疗可能有助于改善血糖控制和降低急性并发症风险。
- 临床决策时可综合考虑早期泵治疗与低血糖昏迷和住院风险降低的关联,但需结合个体情况。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although continuous subcutaneous insulin infusion therapy (ie, insulin pump therapy) is associated with improved metabolic control compared with multiple daily insulin injections in children with type 1 diabetes, it is unclear when it is best to start it after diagnosis. In this study, we aimed to compare the outcomes between early and delayed start of insulin pump therapy in young patients with type 1 diabetes. METHODS: We based the current study on data from the multicentre, prospective diabetes follow-up registry (ie, Diabetes-Patienten-Verlaufsdokumentation [DPV]). The DPV registry comprises 501 diabetes centres from Germany, Austria, Switzerland, and Luxembourg. We included patients diagnosed with type 1 diabetes between 2004 and 2014, who were aged between 6 months and 15 years at the time of diagnosis, who had started insulin pump therapy either within the first 6 months (ie, the early treatment group) or in the second to third year (ie, the delayed treatment group) after diabetes diagnosis, and who were treated with insulin pump therapy for at least 1 year. The outcome parameters included the glycated haemoglobin (HbA1c) values, the cardiovascular risk profile, and rates of acute complications and diabetes-associated hospital admissions (ie, hospitalisation) during the most recent documented treatment year with insulin pump therapy. Statistical models were adjusted for age at diabetes diagnosis, year of diagnosis, sex, immigrant background, use of continuous glucose monitoring, centre size, and the German Index of Socioeconomic Deprivation 2012 terciles. FINDINGS: Our study sample comprised 8332 patients from 311 diabetes centres in Germany, Austria, Switzerland, and Luxembourg. The early treatment group consisted of 4004 (48·1%) of 8332 patients, and the delayed treatment group consisted of 4328 (51·9%). The median diabetes duration during follow-up was 6·7 years (IQR 5·1-8·7 in the early group; 5·0-8·7 in the delayed group) in both groups. Patients with early initiation of insulin pump therapy compared with those with delayed initiation of insulin pump therapy had significantly lower estimated mean HbA1c values (7·9% [95% CI 7·8-7·9] and 62·6 mmol/mol [95% CI 62·1-63·2] vs 8·0% [8·0-8·1] and 64·1 mmol/mol [63·6-64·6]; p=0·0006), and lower rates of hypoglycaemic coma (incidence risk ratio 0·44 [95% CI 0·24-0·79]; p=0·0064) and hospitalisation (0·86 [95% CI 0·78-0·94]; p=0·0016). A better cardiovascular risk profile was observed in patients with early initiation of insulin pump therapy than in those with delayed initiation: an estimated mean systolic blood pressure of 117·6 mm Hg (95% CI 117·2-117·9) versus 118·5 mm Hg (118·2-118·9), p=0·0007; and HDL cholesterol of 62·8 mg/dL (95% CI 62·2-63·5) versus 60·6 mg/dL (60·0-61·2), p<0·0001; however, diastolic blood pressure; concentrations of LDL cholesterol, non-HDL cholesterol, and triglycerides; and estimated body-mass index standard deviation scores during follow-up did not differ significantly between both groups. INTERPRETATION: Our findings provide evidence for improved clinical outcomes associated with the early initiation of insulin pump therapy in children with type 1 diabetes. FUNDING: The German Center for Diabetes Research (Deutsches Zentrum für Diabetesforschung), German Robert Koch Institute, German Diabetes Association, and Diabetes Agenda 2010.
引用
- Kamrath C, Tittel SR, Kapellen TM, et al. Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry. Lancet Child Adolesc Health. 2020. PMID: 33253630. doi:10.1016/S2352-4642(20)30339-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。